PRCT
Procept Biorobotics Corp
17.90$
-0.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 170.9% | 170.9% | 101.5% | 85.4% | 51.0% | 57.7% | 51.1% | 55.5% | 45.8% | 49.2% | 49.7% | 55.1% | 48.8% | 44.3% | 46.2% | 51.2% | 43.8% | 41.0% | 36.8% | 36.0% | 36.1% | 36.7% | 37.1% | 39.4% | 35.1% | 34.0% | 36.3% | |
| -70.9% | -70.9% | -1.5% | 14.6% | 49.0% | 42.3% | 48.9% | 44.5% | 54.2% | 50.8% | 50.3% | 44.9% | 51.2% | 55.7% | 53.8% | 48.8% | 56.2% | 59.0% | 63.2% | 64.0% | 63.9% | 63.3% | 62.9% | 60.6% | 64.9% | 66.0% | 63.7% | |
| 328.1% | 328.1% | 184.8% | 141.0% | 62.9% | 52.8% | 56.7% | 50.1% | 35.3% | 40.2% | 37.3% | 40.7% | 44.0% | 35.1% | 33.0% | 33.3% | 29.4% | 32.8% | 28.5% | 22.1% | 23.7% | 20.3% | 19.9% | 24.9% | 25.8% | 21.3% | 22.9% | |
| – | – | 334.8% | 283.6% | 143.9% | 145.1% | 139.8% | 160.5% | 129.5% | 117.8% | 121.6% | 109.5% | 123.5% | 98.0% | 93.7% | 83.3% | 88.9% | 76.5% | 73.1% | 70.8% | 79.8% | 71.1% | 70.8% | 76.3% | 78.3% | 73.7% | 74.7% | |
| 917.7% | 917.7% | 519.6% | 424.6% | 206.8% | 197.9% | 196.6% | 210.6% | 164.8% | 157.9% | 158.9% | 150.2% | 167.5% | 133.1% | 126.7% | 116.6% | 118.3% | 109.3% | 101.7% | 92.9% | 103.5% | 91.4% | 90.7% | 101.3% | 104.1% | 95.0% | 97.6% | |
| -988.5% | -988.5% | -521.0% | -410.0% | -157.7% | -155.6% | -147.6% | -166.0% | -110.6% | -107.1% | -108.6% | -105.3% | -116.3% | -77.4% | -73.0% | -67.8% | -62.1% | -50.3% | -38.4% | -28.9% | -39.7% | -28.0% | -27.8% | -40.6% | -39.2% | -29.0% | -33.9% | |
| – | – | 65.8% | 55.0% | 20.4% | 16.9% | 16.9% | 14.2% | 10.0% | 8.6% | 7.2% | 3.6% | 3.6% | 2.9% | 2.9% | 2.6% | 2.3% | 1.9% | 2.0% | 1.4% | 1.3% | 1.1% | 1.1% | 1.2% | 1.0% | 0.9% | 1.0% | |
| -1,077.1% | -1,077.1% | -569.9% | -474.3% | -178.3% | -172.0% | -162.7% | -181.0% | -121.0% | -114.9% | -111.1% | -118.5% | -116.7% | -76.4% | -70.1% | -63.1% | -58.3% | -48.0% | -35.9% | -27.6% | -35.8% | -24.7% | -25.7% | -38.8% | -38.1% | -28.3% | -32.5% | |
| – | – | 66.7% | 54.5% | 20.2% | 17.4% | 9.4% | -85.5% | 10.4% | 7.8% | 2.5% | 13.2% | -3.2% | 3.6% | -3.0% | 4.2% | 2.6% | – | -2.3% | – | – | – | – | 0.2% | -0.1% | 0.1% | – | |
| -1,077.1% | -1,077.1% | -569.9% | -474.3% | -178.3% | -172.0% | -162.7% | -181.0% | -121.0% | -114.9% | -111.1% | -118.5% | -116.7% | -76.4% | -70.1% | -63.1% | -58.3% | -48.0% | -35.9% | -27.6% | -35.8% | -24.7% | -25.7% | -39.1% | -38.1% | -28.4% | -32.5% | |
| -928.7% | -928.7% | -470.1% | -397.1% | -145.2% | -145.0% | -136.6% | -159.3% | -105.7% | -102.0% | -100.5% | -112.1% | -109.8% | -71.5% | -64.2% | -57.5% | -53.3% | -43.7% | -31.7% | -24.1% | -32.4% | -21.6% | -22.7% | -35.4% | -35.0% | -25.3% | -29.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.